JUAN
PASQUAU LIAÑO
Researcher in the period 2022-2023
MARÍA DEL CARMEN
HIDALGO TENORIO
PROFESORA ASOCIADA CIENCIAS SALUD
Publications by the researcher in collaboration with MARÍA DEL CARMEN HIDALGO TENORIO (29)
2024
2023
-
EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci
International Journal of Antimicrobial Agents, Vol. 62, Núm. 3
2022
-
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks)
Viruses, Vol. 14, Núm. 3
-
Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections
Scientific Reports, Vol. 12, Núm. 1
-
Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV
Viruses, Vol. 14, Núm. 12
-
Timing in antibiotic therapy: when and how to start, de-escalate and stop antibiotic therapy. Proposals from a stablished antimicrobial stewardship program
Revista Espanola de Quimioterapia, Vol. 35, pp. 102-107
2021
-
Effectiveness of the quadrivalent hpv vaccine in preventing anal ≥ hsils in a spanish population of hiv+ msm aged > 26 years
Viruses, Vol. 13, Núm. 2
-
Risk factors for ≥high-grade anal intraepithelial lesions in MSM living with HIV and the response to topical and surgical treatments
PLoS ONE, Vol. 16, Núm. 2 February
2019
-
ART is key to clearing oncogenic HPV genotypes (HR-HPV) in anal mucosa of HIV-positive MSM
PLoS ONE, Vol. 14, Núm. 10
-
Clinical outcomes of carbapenem de-escalation regardless of microbiological results: A propensity score analysis
International Journal of Infectious Diseases, Vol. 85, pp. 80-87
-
DALBACEN cohort: Dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
Annals of Clinical Microbiology and Antimicrobials, Vol. 18, Núm. 1
-
DOLAMA study: Effectiveness, safety and pharmacoeconomic analysis of dual therapy with dolutegravir and lamivudine in virologically suppressed HIV-1 patients
Medicine (United States), Vol. 98, Núm. 32
-
Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: A preliminary
BMC Infectious Diseases, Vol. 19, Núm. 1
2018
-
5. Antibacterianos
Manejo práctico de los antimicrobianos en medicina (Avicam), pp. 27-110
-
High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, Núm. 9, pp. 555-562
-
High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial
PLoS ONE, Vol. 13, Núm. 4
2017
-
5. Antibacterianos
Manejo práctico de los antimicrobianos en medicina (Avicam), pp. 27-102
-
Risk factors for infection by oncogenic human papillomaviruses in HIV-positive MSM patients in the ART era (2010-2016)
Medicine (United States), Vol. 96, Núm. 39
-
Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM)
AIDS Research and Therapy, Vol. 14, Núm. 1